drugset / Trial / NCT01707667

Study to Investigate Prucalopride vs. Polyethylene Glycol 3350 on Colon Activity

NCT01707667 ↗

Phase 4 Completed 13 enrolled Shire
RandomizedCrossoverOpen-labelTreatment

Summary

To evaluate the different effects of prucalopride and PEG 3350 + electrolytes on colon motor activity in subjects that are chronically constipated.

Timeline

Start
2013-02-27
Primary completion
2013-11-27
Completion
2013-11-27

Outcome

Met primary endpoint

registry analysis (unspecified test); Prucalopride vs PEG 3350; p = 0.012; Mean Difference (Final Values) 5.8 (95% CI 1.6 to 9.9); Linear Mixed-Effect Models Analysis NCT01707667 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator Polyethylene Glycol 3350 Other / unclassified 13.8 g Oral
Subject Prucalopride Small molecule 2 mg Oral

Indications